Processa Pharmaceuticals Inc
(PCSA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2006 | |
| Sales | 107 | 0 |
| Cost of Goods | 67 | N/A |
| Gross Profit | 40 | N/A |
| Operating Expenses | 3,087 | 0 |
| Operating Income | -2,980 | N/A |
| Interest Expense | 315 | 0 |
| Other Income | -391 | 0 |
| Pre-tax Income | -3,686 | 0 |
| Net Income Continuous | -3,686 | N/A |
| Net Income Discontinuous | -841 | N/A |
| Net Income | $-4,526 | $N/A |
| EPS Basic Total Ops | -16,661.67 | N/A |
| EPS Basic Continuous Ops | -10,194.88 | N/A |
| EPS Basic Discontinuous Ops | -2,325.35 | N/A |
| EPS Diluted Total Ops | -16,661.67 | N/A |
| EPS Diluted Continuous Ops | -10,194.88 | N/A |
| EPS Diluted Discontinuous Ops | -2,325.35 | N/A |
| EBITDA(a) | $-2,552 | $N/A |